SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-028760
Filing Date
2019-08-05
Accepted
2019-08-05 16:09:36
Documents
59
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arwr-10q_20190630.htm 10-Q 1869086
2 EX-10.1 arwr-ex101_67.htm EX-10.1 589198
3 EX-31.1 arwr-ex311_6.htm EX-31.1 10488
4 EX-31.2 arwr-ex312_9.htm EX-31.2 10933
5 EX-32.1 arwr-ex321_8.htm EX-32.1 6315
6 EX-32.2 arwr-ex322_7.htm EX-32.2 6562
  Complete submission text file 0001564590-19-028760.txt   6249039

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arwr-20190630.xml EX-101.INS 929771
8 XBRL TAXONOMY EXTENSION SCHEMA arwr-20190630.xsd EX-101.SCH 41094
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20190630_cal.xml EX-101.CAL 44358
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20190630_def.xml EX-101.DEF 149139
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20190630_lab.xml EX-101.LAB 372173
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20190630_pre.xml EX-101.PRE 294203
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 19998705
SIC: 2834 Pharmaceutical Preparations